Veracyte Inc (VCYT)
35.02
+0.71
(+2.07%)
USD |
NASDAQ |
Nov 04, 16:00
35.70
+0.68
(+1.94%)
Pre-Market: 09:01
Veracyte Total Liabilities (Quarterly): 101.80M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 101.80M |
| March 31, 2024 | 81.42M |
| December 31, 2023 | 70.80M |
| September 30, 2023 | 70.88M |
| June 30, 2023 | 78.40M |
| March 31, 2023 | 75.86M |
| December 31, 2022 | 81.22M |
| September 30, 2022 | 77.78M |
| June 30, 2022 | 80.05M |
| March 31, 2022 | 88.40M |
| December 31, 2021 | 91.31M |
| September 30, 2021 | 79.28M |
| June 30, 2021 | 56.26M |
| March 31, 2021 | 50.90M |
| December 31, 2020 | 35.93M |
| September 30, 2020 | 31.43M |
| June 30, 2020 | 30.59M |
| March 31, 2020 | 36.68M |
| December 31, 2019 | 35.76M |
| September 30, 2019 | 29.28M |
| June 30, 2019 | 28.14M |
| March 31, 2019 | 39.76M |
| December 31, 2018 | 40.88M |
| Date | Value |
|---|---|
| September 30, 2018 | 39.66M |
| June 30, 2018 | 39.66M |
| March 31, 2018 | 41.18M |
| December 31, 2017 | 41.44M |
| September 30, 2017 | 40.84M |
| June 30, 2017 | 40.50M |
| March 31, 2017 | 39.26M |
| December 31, 2016 | 41.45M |
| September 30, 2016 | 39.64M |
| June 30, 2016 | 41.08M |
| March 31, 2016 | 40.96M |
| December 31, 2015 | 24.00M |
| September 30, 2015 | 23.04M |
| June 30, 2015 | 17.42M |
| March 31, 2015 | 19.98M |
| December 31, 2014 | 23.46M |
| September 30, 2014 | 23.53M |
| June 30, 2014 | 22.72M |
| March 31, 2014 | 22.16M |
| December 31, 2013 | 23.19M |
| September 30, 2013 | 21.12M |
| June 30, 2013 | 18.75M |
| December 31, 2012 | 14.17M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
30.59M
Minimum
Jun 2020
101.80M
Maximum
Jun 2024
66.04M
Average
75.86M
Median
Mar 2023
Total Liabilities (Quarterly) Benchmarks
| Fonar Corp | 57.46M |
| XWELL Inc | 19.06M |
| ProPhase Labs Inc | 49.60M |
| Applied DNA Sciences Inc | 4.456M |
| OncoCyte Corp | 52.02M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.234B |
| Shareholders Equity (Quarterly) | 1.133B |
| Current Ratio | 4.439 |